We postulate that the compromised immune surveillance induced by enhanced expression of PKM2 and LDHA, and reduced CD8+ effector T-cells might be another contributing factor associated with poor prognosis of the glycolytic phenotype of pancreatic cancer. The gene discussed is CD8A; the disease is pancreatic neoplasm.